Hearing on Food and Drug Administration Activities.

Continuation of hearings to review FDA regulatory policies. Examines regulation of oral contraceptives, particularly the new drug Demulen, FDA drug approval process and labeling regulations, and research on possible health risks of oral contraceptives containing high dosages of estrogen.

Bibliographic Details

Corporate Author:	United States. Congress. House. Committee on Government Operations. Intergovernmental Relations Subcommittee (other agent associated with work.)
Format:	eBook
Language:	English
Published:	[Washington : U.S. G.P.O.], 1970.
Subjects:	Contraceptives. Drugs. Estrogen.
Online Access:	Electronic resource (PDF)